SCHEMBL6601183

SCHEMBL6601183

COc1ccc(C2=NN(C(=O)c3cccc(NC(=O)c4ccncn4)c3)CCC2)cc1OC

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CFTR P13569 5/20 0.47
ALDH1A1 P00352 4/20 0.46
LMNA P02545 2/20 0.46
PKM P14618 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
MAOB P27338 1/20 0.45
PGR P06401 5/20 0.44
POLB P06746 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
MAPT P10636 1/20 0.42
GRM4 Q14833 1/20 0.42
PDE4B Q07343 1/20 0.41
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
KDM4E B2RXH2 1/20 0.41
TP53 P04637 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6603283 0.95 ALDH1A1 (0.43) CFTRALDH1A1LMNAPKMNPSR1
SCHEMBL6601233 0.93 PDE5A (0.46) CFTRALDH1A1LMNAPKMNPSR1
SCHEMBL6601859 0.91 CFTR (0.50) CFTRALDH1A1PKMMAOBPGR
SCHEMBL6602622 0.90 SMN1; SMN2 (0.54) CFTRALDH1A1LMNAPKMNPSR1
SCHEMBL6602100 0.90 MAOB (0.48) CFTRALDH1A1LMNAPKMNPSR1
SCHEMBL6602109 0.89 RAB9A (0.53) CFTRALDH1A1LMNAPKMNPSR1
Hydrochloric Acid SCHEMBL7646213 0.89 MAOB (0.47) CFTRALDH1A1LMNAPKMNPSR1
SCHEMBL6602165 0.88 MAOB (0.48) CFTRALDH1A1LMNAPKMNPSR1
SCHEMBL6603434 0.87 LMNA (0.50) ALDH1A1LMNAPKMNPSR1MAOB
SCHEMBL6600797 0.86 ALDH1A1 (0.48) CFTRALDH1A1LMNAPKMNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0922036-B1 ARYLALKANOYL PYRIDAZINES MERCK PATENT GMBH (DE) 2004-03-24 EP disclosed
US-6479494-B1 THEY INHIBIT SELECTIVELY PHOSPHODIESTERASE IV, WHICH CAUSES AN INCREASE OF THE INTRACELLULAR CAMP LEVEL AS CAMP INHIBITS BONE DECREASING CELLS AND STIMULATES BONE INCREASING CELLS FOR TREATMENT OF OSTEOPOROSIS MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG (DE) 2002-11-12 US disclosed
US-6107295-A Arylalkanoyl pyridazines MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2000-08-22 US disclosed